Fas ligand mRNA levels of circulating leukocytes reflect endothelial dysfunction in hyperlipidemic but not in non-hyperlipidemic patients

Hypertension Research

Volumn 29, Issue 4, 2006, Pages 217-225

  Kotani, Noriko ^a   Fukuo, Keisuke ^b   Yasuda, Osamu ^a   Sugimoto, Ken ^a   Katuya, Tomohiro ^a   Takemura, Yukihiro ^a   Kawamoto, Hidenobu ^a   Yokoi, Toyohiko ^a   Suzuki, Atsuko ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Apoptosis; Atherosclerosis; Endothelium; Hypercholesterolemia; Inflammation

Indexed keywords

APOPTOSIS INDUCING FACTOR; FAS LIGAND; MESSENGER RNA; NEUTRALIZING ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; SIMVASTATIN;

ADULT; AGED; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CELL DEATH; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM LESION; FEMALE; GENE EXPRESSION REGULATION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; LEUKEMIA CELL LINE; LEUKOCYTE; LIPOPROTEIN BLOOD LEVEL; MALE; REAL TIME POLYMERASE CHAIN REACTION; SUPERNATANT; T LYMPHOCYTE;

AGED; ANTILIPEMIC AGENTS; APOPTOSIS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FAS LIGAND PROTEIN; FEMALE; HUMANS; HYPERLIPIDEMIAS; JURKAT CELLS; LEUKOCYTES; LIPOPROTEINS, LDL; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGIONAL BLOOD FLOW; RNA, MESSENGER; SIMVASTATIN; TUMOR NECROSIS FACTORS; UP-REGULATION; VASCULITIS;

EID: 33744958496     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.217     Document Type: Article

References (40)

1. Naghavi M, Libby P, Falk E, et al: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003; 108: 1772-1778.
2. Kario K, McEwen BS, Pickering TG: Disasters and the heart: a review of the effects of earthquake-induced stress on cardiovascular disease. Hypertens Res 2003; 26: 355-367.
3. Hutter R, Valdiviezo C, Sauter BV, et al: Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis. Circulation 2004; 109: 2001-2008.
4. Sata M, Hirata Y, Nagai R: Role of Fas/Fas ligand interaction in ischemia-induced collateral vessel growth. Hypertens Res 2002; 25: 577-582.
5. Durand E, Scoazec A, Lafont A, et al: In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion. Circulation 2004; 109: 2503-2506.
6. Nagata S: Apoptosis by death factor. Cell 1997; 88: 355-365.
7. Sata M, Walsh K: Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP. J Biol Chem 1998; 273: 33103-33106.
8. Shimizu M, Fukuo K, Nagata S, et al: Increased plasma levels of the soluble form of Fas ligand in patients with acute myocardial infarction and unstable angina pectoris. J Am Coll Cardiol 2002; 39: 585-590.
9. Blanco-Colio LM, Munoz-Garcia B, Martin-Ventura JL, et al: 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes. Circulation 2003; 108: 1506-1513.
10. Vaughan CJ, Murphy MB, Buckley BM: Statins do more than just lower cholesterol. Lancet 1996; 348: 1079-1082.
11. Wolfrum S, Jensen KS, Liao JK: Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol 2003; 23: 729-736.
12. Minami M, Atarashi K, Ishiyama A, Hirata Y, Goto A, Omata M: Effects of cholesterol-lowering therapy on pressor hyperreactivity to stress in hypercholesterolemic patients. Hypertens Res 2003; 26: 273-280.
13. Dimmeler S, Haendeler J, Nehls M, Zeiher AM: Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 1997; 185: 601-607.
14. Guijarro C, Blanco-Colio LM, Ortego M, et al: 3-Hydroxy-3-methylglutaryl coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ Res 1998; 83: 490-500.
15. Weis M, Heeschen C, Glassford AJ, Cooke JP: Statins have biphasic effects on angiogenesis. Circulation 2002; 105: 739-745.
16. Fujii K, Abe I, Ohya Y, et al: Risk factors for the progression of early carotid atherosclerosis in a male working population. Hypertens Res 2003; 26: 465-471.
17. Sumino H, Ichikawa S, Kasama S, et al: Effect of transdermal hormone replacement therapy on carotid artery wall thickness and levels of vascular inflammatory markers in postmenopausal women. Hypertens Res 2005; 28: 579-584.
18. Kohara K, Tabara Y, Tachibana R, Nakura J, Miki T: Microalbuminuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J-SHIPP) study. Hypertens Res 2004; 27: 471-477.
19. Furumoto T, Saito N, Dong J, Mikami T, Fujii S, Kitabatake A: Association of cardiovascular risk factors and endothelial dysfunction in Japanese hypertensive patients: implications for early atherosclerosis. Hypertens Res 2002; 25: 475-480.
20. Celermajer DS, Sorensen KE, Gooch VM, et al: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
21. Moriguchi J, Itoh H, Harada S, et al: Low frequency regular exercise improves flow-mediated dilatation of subjects with mild hypertension. Hypertens Res 2005; 28: 315-321.
22. Benjamin EJ, Larson MG, Keyes MJ, et al: Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 2004; 109: 613-619.
23. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
24. Diez-Roux G, Lang RA: Macrophages induce apoptosis in normal cells in vivo. Development 1997; 124: 3633-3638.
25. Asai K, Kudej RK, Shen YT, et al: Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vasc Biol 2000; 20: 1493-1499.
26. Liao JK, Shin WS, Lee WY, Clark SL: Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995; 270: 319-324.
27. Ohara Y, Peterson TE, Harrison DG: Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-2551.
28. Aprahamian T, Rifkin I, Bonegio R, et al: Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J Exp Med 2004; 199: 1121-1131.
29. Schonbeck U, Gerdes N, Varo N, et al: Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. Circulation 2002; 106: 2888-2893.
30. Eto M, Kozai T, Cosentino F, Joch H, Luscher TF: Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Circulation 2002; 105: 1756-1759.
31. Okura Y, Takao M, Zhang B, Nakashima Y, Saku K: Cardiovascular risk factor profiles and endothelial function in coronary artery disease patients treated with statins. Hypertens Res 2004; 27: 723-729.
32. Ridker PM, Rifai N, Clearfield M, et al: Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344: 1959-1965.
33. Hozawa A, Ohmori K, Kuriyama S, et al: C-reactive protein and peripheral artery disease among Japanese elderly: the Tsurugaya Project. Hypertens Res 2004; 27: 955-961.
34. Miwa K, Asano M, Horai R, Iwakura Y, Nagata S, Suda T: Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med 1998; 4: 1287-1292.
35. Chang MK, Binder CJ, Miller YI, et al: Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med 2004; 200: 1359-1370.
36. Kang SM, Schneider DB, Lin Z, et al: Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med 1997; 3: 738-743.
37. Allison J, Georgiou HM, Strasser A, Vaux DL: Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci U S A 1997; 94: 3943-3947.
38. Hohlbaum AM, Gregory MS, Ju ST, Marshak-Rothstein A: Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J Immunol 2001; 167: 6217-6224.
39. Sato T, Machida T, Takahashi S, et al: Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells. J Immunol 2004; 173: 285-296.
40. Medan D, Wang L, Toledo D, et al: Regulation of Fas (CD95)-induced apoptotic and necrotic cell death by reactive oxygen species in macrophages. J Cell Physiol 2005; 203: 78-84.